NxStage Announces Second Quarter 2012 Investor Conference Schedule - PR Newswire (press release) PDF Print
<![CDATA[ .translangcomp{ float:left; clear:left; margin-top:15px; *margin-top:-2px; margin-left:90px } ]]> <![CDATA[ .news-print1{background:url(http://content.prnewswire.com/designimages/print_PRN.jpg) no-repeat 2px 8px; display: block; font-size:12px; font-weight:100; height:10px; padding:11px 5px 11px 30px; } ]]><![CDATA[ .cf_arrowtail{ visibility:hidden; } ]]>

LAWRENCE, Mass., May 10, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will participate in the following schedule of investor conferences.  A webcast of the event will be made available at http://ir.nxstage.com/ at the time of each conference.  

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )

Jefferies 2012 Global Healthcare Conference 
New York, NY
Tuesday, June 5, 2012
1:30 p.m. ET

William Blair 2012 Growth Stock Conference 
Chicago, IL    
Four Seasons Hotel
Tuesday, June 12, 2012
2:10 p.m. CT

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank's plans to present at these conferences.  NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.

Contact:

Kristen K. Sheppard, Esq.
Investor Relations
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

SOURCE NxStage Medical, Inc.

Back to top

RELATED LINKS
http://www.nxstage.com

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.